NEW ASPECTS OF TREATING CHRONIC PAIN: MULTICENTER, OPEN-LABEL CLINICAL TRIAL OF MEDICATION KETONAL DUO IN PATIENTS WITH DEGENERATIVE JOINT DISEASES

The results of multicenter, open-label trial aimed at assessing the effectiveness, safety, and compliance of medication Ketonal Duo in 602 patients with osteoarthritis (OA) are presented. The trial duration was 28 days. The medication demonstrated a reliable analgesic effect and good tolerance; adve...

Full description

Saved in:
Bibliographic Details
Published inNauchno-prakticheskai͡a︡ revmatologii͡a Vol. 52; no. 2; pp. 195 - 201
Main Authors Chichasova, N. V., Kamalova, R. G., Plaksina, T. V., Popov, A. A.
Format Journal Article
LanguageEnglish
Russian
Published IMA PRESS LLC 17.06.2014
Subjects
compliance
evaluation of the effectiveness and safety
ketonal duo
osteoarthritis
Online AccessGet full text

Cover

More Information
Summary:The results of multicenter, open-label trial aimed at assessing the effectiveness, safety, and compliance of medication Ketonal Duo in 602 patients with osteoarthritis (OA) are presented. The trial duration was 28 days. The medication demonstrated a reliable analgesic effect and good tolerance; adverse events were observed in 4.7% of patients. The effect was observed in 97.9% of patients with OA according to the physician's opinion and in 99.1% as reported by the patients. Most patients and physicians consider the medication to have maximal convenience.
ISSN:1995-4484
1995-4492
DOI:10.14412/1995-4484-2014-195-201